3 active trials 1 recruiting 9 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-10 | NCT07811232 A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers | Phase 1/2 | Not Yet Recruiting |
| 2026-09-10 | NCT07811297 A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers | Phase 1/2 | Not Yet Recruiting |
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05363280 | Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or… | Small Cell Lung Cancer | Recruiting | 2026-05-08 |
| Phase 1/2 | ||||
| NCT07811232 | A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers | Endometrial Neoplasms | Not Yet Recruiting | 2026-09-10 |
| NCT07811297 | A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers | Endometrial Neoplasms | Not Yet Recruiting | 2026-09-10 |
Endometrial Cancer (2) · Sarcoma (2) · Breast Cancer (1) · Glioblastoma (1) · Kidney Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Ovarian Cancer (1) · Small Cell Lung Cancer (1)